Pharma

Tackling AMR and medicine shortages in the EU

How can the EU’s pharmaceutical legislation help tackle current challenges, including medicine shortages and antimicrobial resistance, across Europe? We put the question to Rainer Becker, Director for Medical Products and Innovation at DG SANTE.

Medicare considers coverage expansion for weight-loss medication

Aiming to tackle the high risk of heart problems among older Americans with obesity, Medicare is contemplating an expansion of coverage for a weight-loss medication known as semaglutide.

From drug disposal to water contamination: Unpacking pharmaceutical pollution

Lorna Rothery spoke to Health Care Without Harm (HCWH) Europe about the impact of pharmaceutical pollution and the barriers that need to be overcome to achieve a greener, more sustainable industry.

3D printing brings personalised drugs to your local pharmacy

Imagine a world where children's medicine tastes like chocolate, seniors can take just one pill for all their daily medications, and you can get a drug made specifically for your unique health needs right at your local pharmacy.

Navigating the impact of COVID-19 on childhood vaccinations

Anne Pham-Huy and Antonella Pucci from Immunize Canada discuss the impact of the COVID-19 pandemic on routine vaccinations for children.

The role of green chemistry in healthcare

Ewan Townsend, Co-chair of Arnold & Porter’s Sustainability Committee, discusses the pharmaceutical sector’s shift towards environmentally friendly green chemistry.

Scientists discover cost-effective method to produce key drug molecules

Scientists at Scripps Research have revealed a new approach to synthesising crucial molecules used in drug development.

Cannabis use linked to increased risk of heart attack and stroke

Analysis of over 430,000 adults in the United States has unveiled concerning connections between cannabis consumption and heightened risks of heart attack and stroke.

How can cannabis help with chronic pain?

A staggering 51.6 million Americans live with pain daily; Ellen Smith from the U.S. Pain Foundation tells us about how medical cannabis supports her management of chronic pain.

Secarna: Next generation antisense therapeutics

Leading independent European antisense drug discovery company, Secarna, aims to bring novel and effective antisense therapeutic options to an increasing number of patients. CEO Alexander Gebauer tells us how.

Medicinal cannabis: The future of chronic pain treatment?

Alberto Sainz Cort to discuss the prevalence of chronic pain and opioid use in the United States, as well as medical cannabis as a potential treatment for pain.

Antibiotic resistance threatens young lives worldwide

Antibiotics used to treat common infections in infants and children are becoming increasingly ineffective worldwide.

CBD and growing trust: Sowing the seeds of good health

Over the past seven years, CBD wellness company Savage Cabbage has grown from a small family-run business into a globally recognised, high-quality brand, trusted as an authoritative voice, even in the corridors of Westminster.

Cannabis use disorder linked to increased cardiovascular disease risk

A study highlights a 60% increased cardiovascular disease risk in individuals with cannabis use disorder, concerns about heart attacks.

Finger sweat test detects antipsychotic drugs in patients

Innovative finger sweat test provides patients with a more comfortable and non-invasive way to monitor antipsychotic drug levels.

£5 million fund to combat fatal drug deaths in the UK

In a concerted effort to combat the alarming issue of fatal drug deaths across the UK, the government has allocated £5 million to support 12 groundbreaking projects.

Innovative paediatric research: Investigating the 3D printing of medication

The NIH has awarded a grant of $3 million in the hope of supporting the 3D printing of medication tailored towards helping paediatric patients.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders